Certified by Founder Lodge
VerImmune
United States - Washington DC
START UP
1 Disclosed Funding Rounds $3,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
VerImmune is advancing Anti-tumor Immune Redirection (AIR):
A Breakthrough Therapy that Redirects Pre-Existing Immune Memory
from Childhood Vaccination or Infection to Fight Cancer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 21 ,2023 | Unknown | $3,000,000 |
Mana Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Windmill(US) | $12,000,000 | (Apr 29, 2026)
TrialClinIQ | $150,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
